BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan W, Liu Z, Liu J, Xia Y, Hu K, Yu J. Application of Chimeric Antigen Receptor T Cells in the Treatment of Hematological Malignancies. Biomed Res Int 2020;2020:4241864. [PMID: 33062678 DOI: 10.1155/2020/4241864] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Abbasi S, Totmaj MA, Abbasi M, Hajazimian S, Goleij P, Behroozi J, Shademan B, Isazadeh A, Baradaran B. Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies. Cancer Med 2022. [PMID: 36583504 DOI: 10.1002/cam4.5551] [Reference Citation Analysis]
2 Tannoury M, Garnier D, Susin SA, Bauvois B. Current Status of Novel Agents for the Treatment of B Cell Malignancies: What's Coming Next? Cancers (Basel) 2022;14. [PMID: 36551511 DOI: 10.3390/cancers14246026] [Reference Citation Analysis]
3 Li W, Liang L, Liao Q, Li Y, Zhou Y. CD38: An important regulator of T cell function. Biomed Pharmacother 2022;153:113395. [PMID: 35834988 DOI: 10.1016/j.biopha.2022.113395] [Reference Citation Analysis]
4 Bashar SB, Akhter Z, Saha BC, Himaloy MMI, Kulsum U, Rahman MR. CAR T Cell Immunotherapy That Revolutionary Breakthrough in Human Oncology Treatment: A Review. PP 2022;13:483-515. [DOI: 10.4236/pp.2022.1311036] [Reference Citation Analysis]
5 Marofi F, Rahman HS, Achmad MH, Sergeevna KN, Suksatan W, Abdelbasset WK, Mikhailova MV, Shomali N, Yazdanifar M, Hassanzadeh A, Ahmadi M, Motavalli R, Pathak Y, Izadi S, Jarahian M. A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions. Front Immunol 2021;12:681984. [PMID: 34248965 DOI: 10.3389/fimmu.2021.681984] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]